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Abstract 
Epidemiological evidence suggests an inverse correlation between wine consumption and the incidence 
of cardiovascular and neurodegenerative disorders. Although white wines are generally low in 
polyphenol content as compared to red wines, Champagne wine has been shown to contain relatively 
high amounts of phenolic acids that may exert protective cellular actions in vivo.  Recent evidence 
suggest that Champagne phenolic acids may express their beneficial properties through their 
interaction with cellular signaling pathways and related machinery that mediate cell function under both 
normal and pathological conditions. In this review we aim to provide an overview of the role that 
Champagne consumption plays in maintaining cardiovascular health and cognitive function. We discuss 
epidemiological data, human intervention study findings, as well as animal and in vitro studies in support 
of these actions and we consider how their biological mechanisms at the cellular level may underpin 
their physiological effects. Together, these data indicate that polyphenols present in Champagne may 
hold cardioprotective and neuroprotective potential in delaying the onset of degenerative disorders. 
  
Introduction 
Despite the well-established harmful effects of heavy alcohol intake [1], epidemiological studies have 
reported that a low to moderate intake of wine (1-2 glasses per day), may reduce the risk of 
cardiovascular disease and cognitive impairment [2-5]. In particular, a J-shaped relationship between 
the amount of wine consumed and the risk of cardiovascular disease, such as hypertension, has been 
previously described [6-7]. These observations have been further substantiated by series of large scale, 
cross sectional and prospective studies, which have almost universally demonstrated a strong inverse 
correlation between wine consumption and the risk of cardiovascular disease [8]. In addition, incidence 
data from the so-called Personnes Agees Quid [2] study demonstrated that people drinking three to 
four glasses of wine per day had an 80% decreased incidence of dementia and Alzheimer's disease 
three years later, compared to those who drank less or did not drink at all [4]. Such protection is believed 
to be in large part attributable to the intake of specific polyphenols present in great quantity in wine. In 
particular, flavonoids, a subclass of polyphenols, have been ascribed to exert anti-inflammatory 
properties [9] and to modulate signalling pathways that regulate nitric oxide production [10] and 
neuronal survival [11].  As such, there is a great interest in the potential of regular and moderate wine 
consumption to counteract vascular ageing and to delay the onset of neurological disorders, such as 
Alzheimer’s disease and dementia [12-14].  
Although red wines contain high levels of flavonoids and other phenolics relative to white wines [15], 
Champagne wine is relatively rich in phenolic compounds (Table 1) such as hydroxybenzoic acids, 
hydroxycinnamic acids (and their tartaric derivative esters), phenolic alcohols and phenolic aldehydes 
[16-17]. The phenolic composition varies with a wide range of factors, including species, variety, 
season, growing conditions, and processing practices [18]. The increased levels of phenolic compounds 
in Champagne wine compared to other white wines, derive predominantly from the two red grapes, 
Pinot Noir and Pinot Meunier, which are used in its production along with the white grape Chardonnay 
[19]. Moderate Champagne consumption has been shown to exert a number of effects in vivo, including 
modulation of peripheral serotonin and dopamine release [20] and to increase plasma vitamin A 
concentration [21]. In addition, Champagne polyphenols have been shown to protect primary neuronal 
cells against peroxynitrite-induced injury [16], a physiologically relevant oxidizing species which has 
been implicated in vascular wall pathology [22] and neurodegeneration [23].  As such, Champagne wine 
can deliver significant quantities of phenolic compounds capable of mediating changes in 
cardiovascular health and cognitive performance.  In this manuscript, we will review the effects of 
Champagne wine on vascular health and cognitive functions and we will briefly describe their 
intracellular targets underlying their protective effects. 
 
Champagne wine and vascular health 
Cardiovascular disease (CVD), in particular coronary heart disease and stroke, is a major cause of 
mortality in the Western countries. Epidemiological and human intervention studies have suggested 
that a daily and moderate consumption of red or white wine is associated with a lower incidence of CVD 
[24]. Many of the effects of red wine are compatible with the action of wine-derived polyphenols on 
endothelium-derived nitric oxide (NO•) production [25], whilst white wine effects may result from the 
synergistic actions of polyphenols and other phenolic constituents on LDL oxidation and platelet function 
[26].  Moderate red wine intake has also been associated with a reduced coronary artery disease 
mortality [27-28], through its ability to improve endothelial function [29], to induce an acute increase in 
endothelium-dependent flow-mediated dilatation [30-31] and to inhibit endothelin-1 synthesis [32-33].   
In particular, these biological effects have been linked to flavonoids, hydroxycinnamates and phenolic 
acids present in great concentration in these wines [34].  Following consumption, nanomolar quantities 
of flavonoids and other polyphenols enter the circulation [34-35] where they may act to improve nitric 
oxide bioavailability and/or inhibit endothelin-1 (ET-1) [36-37].  In support of this statement, the 
cardioprotective effects of white wines have been reported [38-39], although they contain lower 
concentration of flavonoids and induce reduced vascular effects when compared to red wines [40-41].  
Moderate Champagne wine consumption has also been shown to exert a number of effects in vivo, 
effecting peripheral serotonin and dopamine release [20] and increasing plasma vitamin A 
concentration [21].  In addition, Champagne wine polyphenols have also been shown to protect cells 
against injury induced by peroxynitrite [16], a physiologically relevant oxidizing species which has been 
implicated in vascular wall pathology [22, 42].   
Recently we reported that moderate consumption of Champagne wine, but not a control matched for 
alcohol, carbohydrate and fruit-derived acid content, improved microvascular blood flow and vascular 
responsiveness in healthy volunteers [43].  By using Laser Doppler and iontophoresis (LDI), we 
demonstrated that absorbed hydroxycinnamates and their metabolites influenced vascular function 
(Figure 1) by inducing an acute change in endothelium-independent vasodilatation at 4, 6 and 8 h post 
consumption, whilst the control did not induce any changes in vascular reactivity [43]. These effects 
were accompanied by an acute decrease in the concentration of matrix metalloproteinase MMP-9 and 
a significant decrease in plasma levels of oxidising species. These biological effects were paralleled by 
a urinary excretion of phenolic metabolites. In particular, the mean total excretion of hippuric acid, 
protocatechuic acid and isoferulic acid were all significantly greater following the Champagne wine 
intervention compared to control intervention, suggesting that they may be responsible for the observed 
vascular activity [43]. Together, these data suggest that consumption of Champagne wine phenolic 
acids may enhance microvascular blood flow for a sustained period of time after consumption, through 
the maintenance of local nitric oxide levels.  Altogether, these results suggest that Champagne wine 
has some short-term effects on the blood vessels that are not solely caused by its alcohol content. 
However, it would be premature to extrapolate the “proxy” outcomes of blood vessel dilation to clinical 
outcomes, such as heart disease. 
 
Champagne wine and cognitive function 
Polyphenols-rich foods/beverages have received much attention with regards to their neuroprotective 
effects [44], including a potential to protect neurons against neurotoxin-induced injury [45-46], to 
suppress neuroinflammation [47], and to promote memory and learning [48-51]. Despite the well-
established harmful effects of heavy alcohol intake [1], epidemiological data suggest that moderate 
wine consumption may reduce the incidence of age-related dementia, including Alzheimer’s disease [4, 
52-53].  As such, there is an interest in the potential of regular, moderate wine consumption to 
counteract normal brain ageing and to improve memory and learning, through its potential to deliver 
relatively high amounts of flavonoids and phenolic acids [12-13].  Animal data support these findings 
and indicate that moderate consumption of red wine attenuates Aβ-neuropathology in a mouse model 
of Alzheimer's disease [54].  In a recent rodent study we reported that Champagne wine is also capable 
of enhancing spatial working memory (without altering motor performance) in aged animals [55].  In 
contrast, moderate alcohol intake failed to induce spatial memory changes.  These observations are in 
agreement with those observed following long-term red wine intake in a similar model of hippocampal-
dependent spatial memory [56].  The effects of Champagne on spatial memory (Figure 2) were 
paralleled by a number of changes in hippocampal and cortical protein expression, which may explain 
performance on spatial memory tasks.  Targeted protein arrays indicated that Champagne induced the 
differential expression of a number of hippocampal and cortical proteins involved in signal transduction, 
neuroplasticity, apoptosis and cell cycle regulation [55]. Most notably, we observed the differential 
modulation of a range of proteins, such as brain-derived neurotrophic factor (BDNF), cAMP response 
element-binding protein (CREB), p38, dystrophin, 2',3'-Cyclic-nucleotide 3'-phosphodiesterase 
(CNPase), mammalian target of rapamycin (mTOR), B-cell lymphoma2-extra large protein (Bcl-xL) in 
response to Champagne supplementation compared to the control drink, and the modulation of mTOR, 
Bcl-xL and CREB in response to alcohol supplementation [55].  
CNPase is a myelin-associated enzyme that constitutes around 4% of total CNS myelin protein, and is 
thought to undergo significant age-associated changes [57], and is reduced in Alzheimer’s disease and 
Down’s syndrome patients [58].  Furthermore, Champagne-induced hippocampal increases in the 
cytoskeletal associated protein, dystrophin, may be beneficial as a lack of this protein in the 
hippocampus has been associated with impaired cognitive function [59], spatial memory [60] and long-
term potentiation [61].  Indeed, patients lacking dystrophin in the hippocampus and neocortex (due to 
mutation in the dystrophin gene) display a range of cognitive deficits [62].  Intervention with the phenolic 
rich Champagne also led to the increased expression of a range of ‘other’ cytoskeletal proteins, 
including plakoglobin (γ-catenin), spectrin, calponin, cytokeratin pep4 and pep19, myosin Va and Focal 
Adhesion Kinase [55].  Such proteins facilitate complex neuronal network formation in the brain and 
operate with neuronal membrane proteins (e.g., ion channels, scaffolding proteins, and adaptor 
proteins) at sites of synaptic contacts to regulate synaptogenesis and coordinate synaptic strength [63-
64].  Our data therefore suggest that smaller phenolics such as gallic acid, protocatechuic acid, tyrosol, 
caftaric acid and caffeic acid, in addition to flavonoids, are capable of exerting improvements in spatial 
memory via the modulation in hippocampal signalling and protein expression. 
 
Mechanisms of action 
Champagne wine consumption has been observed to improve acute vascular function [43], in a similar 
manner to that of red wine [65-66]. Champagne wine and specifically its phenolic metabolites may affect 
vascular function by improving local nitric oxide bioavailability by two potential mechanisms.  Firstly, 
they may increase the local half-life of NO• via reaction with reactive oxygen species, such as 
superoxide [67].  Secondly, phenolic metabolites, such as those excreted post champagne 
consumption, may mimic NADPH oxidase inhibitors [68], such as apocynin thereby reducing the cellular 
production of superoxide and increasing the half-life of NO•, without any change in the rate of NO• 
synthesis [69].  Furthermore, tyrosol, caffeic acid, and gallic acid, phenolic compounds found at 
relatively high concentrations in Champagne, have been shown to potently inhibit peroxynitrite-induced 
cellular injury at physiologically relevant concentrations (0.1 to 10 μM) [16], whilst nanomolar levels of 
tyrosol, caffeic acid and p-coumaric acid protect cortical neurons against 5-S-cysteinyl-dopamine 
induced injury [70].  Indeed, the level of protection induced by these phenolics was equal to, if not 
greater than, that observed for similar concentration of the flavonoids, (+)-catechin, (-)-epicatechin and 
quercetin [70]. The hydroxycinnamate, caffeic acid, has also been shown to be neuroprotective, 
counteracting inflammatory injury induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by 
decreasing the production of a number of inflammatory cytokines, down-regulating the expression of 
iNOS, COX-2 and glial fibrillary acidic protein and lowering the production of NO and PGE₂ [71].  In 
addition, caffeic acid phenethyl ester may protect cerebellar granule neurons against glutamate-induced 
neuronal death via inhibition of p38 phosphorylation and caspase-3 activation [72] and significantly 
prevents hypoxic-ischaemic-induced neonatal rat brain damage in the cortex, hippocampus and 
thalamus [73].  Indeed, for any polyphenol to exert direct neuroprotective actions they must also 
undergo permeation of the blood brain barrier (BBB), something that has been reported for both 
flavonoids and hydroxycinnamates [74].  However, whilst the ability of flavonoids to cross the BBB is 
believed to be dependent on lipophilicity, small phenolics are thought to transverse the BBB via amino 
acid transporters, such as has been reported for 4-ethylcatechol [75].  Furthermore, caffeic acid shares 
structural similarities with L-DOPA and, as such, may undergo BBB transport via catecholamine 
transporter systems.  
It is well reported that flavonoids may exert cellular action by interacting with the PI 3-kinase, Akt/PKB 
and MAP kinase signalling pathways [11].  Smaller phenolics, such as caffeic acid or tyrosol, may also 
participate in cellular interactions of this nature [76], or may directly react with toxic intermediates, as 
has been observed for p-coumaric acid [77]. All together, these processes act to maintain the number 
and quality of synaptic connections in the brain, a factor known to be essential for efficient long term 
potentiation (LTP), synaptic plasticity and ultimately the efficient working of memory.  
 
Conclusions 
The development of cardiovascular and cognitive impairment is a complex process that begins even in 
the absence of a symptomatic disease [78].  Human clinical trials and animal studies have identified 
polyphenol-rich foods and beverages as being capable of delaying the onset of age-related vascular 
and cognitive impairment [44, 79-83].  Polyphenols present in such foods have been postulated to evoke 
protection through the actions of absorbed flavonoids and their metabolites at the cellular level, 
enhancing existing endothelial and neuronal function and/or stimulating cell regeneration [44, 79, 83-
84].  Although antioxidant mechanisms cannot be excluded [85], recent data sets suggest that such 
effects are mediated by their ability to modulate endothelial and neuronal signalling [86-87], to stimulate 
neurotransmitter release [88], to increase vascular blood flow [89] and even to stimulate hippocampal 
neurogenesis [90].  We previously provided evidence that moderate Champagne wine consumption 
induces improvements in vascular health and cognitive function, dependent on the potential of 
Champagne phenolic compounds to modulate endothelial and neuronal cell signalling [70, 91], and to 
enhance blood flow in vivo. Altogether, these results suggest that Champagne wine consumption holds 
a potential to limit neurodegeneration and is capable of vascular improvements [43, 55, 92]. However, 
the pharmacological potential of these natural compounds still remains to be translated in humans in 
clinical conditions. The challenge ahead therefore, is to proceed cautiously until rigorous randomized 
controlled clinical trials have been undertaken to determine whether Champagne wine polyphenols 
and/or their in vivo metabolites have efficacy in patients suffering from cardiovascular episodes or from 
loss of neuronal function.  
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 Table 1. Phenolic compounds in Champagne wine 
Phenolic compounds  (mg/L) 
gallic acid 0.66 
protocatechuic acid 0.50 
tyrosol 8.46 
caftaric acid 5.01 
caffeic acid 1.43 
total phenolics 16.06 
 
  
Figure legends 
Figure 1. Postulated effects of Champagne wine phenolics on the cardiovascular system 
Figure 2. Postulated effects of Champagne wine phenolics on memory and cognition 
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